Tag - medicine

 
 

MEDICINE

Japan Times
WORLD / Science & Health
Apr 18, 2022
Is COVID more dangerous than driving? How scientists are parsing COVID-19 risks.
Even two years into the pandemic, the coronavirus remains new enough, and its long-term effects unpredictable enough, that measuring the threat posed by an infection is a thorny problem.
Japan Times
JAPAN / Science & Health
Apr 17, 2022
Kyoto University eyes providing gene-edited iPS cells from 2023
The CiRA Foundation has already developed iPS cells using blood from donors who have types of immunity that make them less prone to transplant rejections.
Japan Times
WORLD / Science & Health
Apr 12, 2022
India hopes ‘Pharma City’ will break China’s grip on industry
It's a vast project that shows how governments are growing increasingly concerned about China's stranglehold over drug supplies — as well as the challenges they face in loosening it.
Japan Times
JAPAN
Apr 12, 2022
Dental fees to jump in Japan as palladium prices surge on Ukraine war
The change is expected to translate into a rise of several hundred yen in the cost for patients younger than 70 for each tooth treated with 'silver' fillings.
Japan Times
COMMENTARY / World
Apr 11, 2022
We need better COVID-19 booster shots, not more of the same
There are 100 new Covid vaccines in development. One of them could offer better protection against omicron.
Japan Times
ASIA PACIFIC
Apr 10, 2022
With a $2.1 million cure their only hope, Indian parents plead for help online
India makes many of the world's drugs, but treatments for rare diseases like spinal muscular atrophy are imported and prohibitively costly.
Japan Times
BUSINESS
Apr 9, 2022
Japan's Eisai still seeking accelerated U.S. review of Alzheimer's drug
The firm said it plans to seek a quick approval even after the Medicare health plan decided to limit coverage of medicines approved in that manner.
Japan Times
JAPAN / Science & Health
Apr 4, 2022
Japan team proves iPS-based cornea transplants are safe in first clinical trial
Three of the patients in the clinical trial experienced improved eyesight, with one improving from 0.15 to 0.7, the Osaka University team said.
Japan Times
BUSINESS / Companies
Mar 28, 2022
Activist fund executives on board bolstered Olympus, CEO says
Olympus's shares have more than doubled since ValueAct, a U.S. hedge fund, persuaded Olympus to accept its director nominations in 2019.
Japan Times
WORLD / Science & Health
Mar 27, 2022
Second vaccine booster significantly lowers COVID-19 death rate: Israeli study
Senior citizens who received a second booster of the Pfizer-BioNTech COVID-19 vaccination had a 78% lower mortality rate from the disease than those who got one only.
Japan Times
LIFE / Lifestyle
Mar 27, 2022
How long should it take to grieve? Psychiatry has come up with an answer.
Will categorizing prolonged grief as a mental disorder help people in need get access to crucial treatment or hurt those who simply take longer to overcome loss?
Japan Times
WORLD / Science & Health / FOCUS
Mar 25, 2022
Drugmakers and scientists begin the hunt for long COVID treatments
Leading drugmakers, including those who have launched pills and monoclonal antibodies for COVID-19, are having early discussions with researchers about how to target the disease.
Japan Times
JAPAN / FOCUS
Mar 15, 2022
Japanese firms near domestic rollout of their COVID-19 vaccines
Several companies are expecting to introduce their shots in the coming fiscal year, a major step in Japan reducing its reliance on foreign vaccine manufacturers.
Japan Times
BUSINESS
Mar 15, 2022
Drugmakers pause trials in Russia while still sending medicine
Major pharmaceutical firms are seeking to strike a balance between international opprobrium over Russia's invasion of Ukraine and the needs of sick patients.
Japan Times
ASIA PACIFIC
Mar 13, 2022
China fires mayors and closes schools as COVID-19 outbreak spreads
China's National Health Commission announced Saturday that another 1,524 locally transmitted coronavirus cases had been detected in provinces across mainland China.
Japan Times
JAPAN
Mar 11, 2022
Fujifilm to halt enrollment in Avigan trial for COVID-19
The emergence of the omicron variant, which usually causes milder infections, made it tough to determine the drug's effectiveness in preventing severe symptoms, the company said.
Japan Times
WORLD / Science & Health
Mar 10, 2022
U.S. man with transplanted genetically modified pig heart dies
The patient, David Bennett, 'wasn't able to overcome what turned out to be the devastating debilitation' caused by the heart failure he experienced before the transplant.
Japan Times
WORLD / Science & Health
Mar 10, 2022
The humble cough drop could be used to map omicron’s spread
Soaring sales of lozenges, gargles and other over-the-counter medication has squeezed supplies — even in countries where cases are falling.
Japan Times
COMMENTARY / World
Mar 9, 2022
Crispr might actually live up to its immense hype
The Nobel prize-winning technology is moving from a concept to the clinic at a breathtaking pace.
Japan Times
ASIA PACIFIC
Mar 6, 2022
Hong Kong can still achieve COVID-zero, official says
Hong Kong is battling its worst wave yet of COVID-19, which is claiming the lives of at least a hundred people a day.

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'